Until now, patients who suffered heart attacks five to 10 years prior were faced with a 20-40 percent chance of mortality. Today thanks to JV-100, a DNA-based gene therapy that directly targets a person’s own stem cells to the scarred area, necessary repairs may be made through a simple catheter …
